The latest financial statement is for the quarter ending 2026-03-31.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net (loss) | -4,354 | -6,577 | -4,348 | -7,300 |
| Depreciation | 6 | 7 | 6 | 10 |
| Stock-based compensation | 739 | 618 | 480 | 872 |
| Impairment loss on investment | - | 0 | 500 | - |
| Bad debt | - | 0 | - | - |
| Accounts receivables | -19 | 0 | -29 | 48 |
| Prepaid expenses and other assets | -41 | -351 | -286 | -371 |
| Accounts payable | -75 | - | 91 | -50 |
| Accounts payable and accrued liabilities | - | 52 | - | - |
| Accrued payroll and related expenses | 12 | -129 | 33 | 94 |
| Other liabilities | -726 | -89 | -81 | -781 |
| Net cash used in operating activities | -4,297 | -5,808 | -3,004 | -6,832 |
| Purchase of property and equipment | - | 0 | 17 | 0 |
| Purchase of investments | 0 | 0 | 4,769 | 11,411 |
| Proceeds from sale or maturity of investments | 3,524 | 5,081 | 7,638 | 12,247 |
| Net cash provided by investing activities | 3,524 | 5,081 | 2,852 | 836 |
| Proceeds from exercise of options | - | 6 | - | - |
| Payment of payroll taxes on equity awards | 1 | 860 | 12 | 7 |
| Net cash used in financing activities | -1 | -854 | -12 | -7 |
| Net change in cash and cash equivalents | -774 | -1,581 | -164 | -6,003 |
| Cash and cash equivalents, beginning of period | 15,548 | 17,129 | 23,296 | - |
| Cash and cash equivalents, end of period | 14,774 | 15,548 | 17,129 | - |